Oral mucous membrane pemphigoid: Complete response to topical tacrolimus

Acta Dermato-Venereologica

Volumn 91, Issue 5, 2011, Pages 604-605

  Lee, Haur Yueh ^a   Blazek, Claudia ^a   Beltraminelli, Helmut ^a   Borradori, Luca ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYMETHYLCELLULOSE; COMPLEMENT COMPONENT C3; ETHYL PARABEN; IMMUNOGLOBULIN G; SODIUM CHLORIDE; TACROLIMUS;

AGED; AQUEOUS SOLUTION; BASEMENT MEMBRANE; CASE REPORT; CHRONIC KIDNEY DISEASE; DISEASE DURATION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART ATRIUM FIBRILLATION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; ISCHEMIC HEART DISEASE; LETTER; MALE; MEDICAL HISTORY; MOUTH MUCOSA; MOUTH PLAQUE; MOUTH ULCER; MUCOUS MEMBRANE PEMPHIGOID; ORAL BIOPSY; PRIORITY JOURNAL; SKIN EDEMA; STROKE; TREATMENT DURATION; TREATMENT RESPONSE;

ADMINISTRATION, TOPICAL; AGED, 80 AND OVER; BIOPSY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MOUTH MUCOSA; MOUTHWASHES; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; TACROLIMUS; TREATMENT OUTCOME;

EID: 80052015819     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1142     Document Type: Letter

References (10)

1. Mutasim DF, Pelc NJ, Anhalt GJ. Cicatricial pemphigoid. Dermatol Clin 1993; 11: 499-510
2. Chan LS, Yancey KB, Hammerberg C, Soong HK, Regezi JA, Johnson K, et al. Immune-mediated subepithelial bliste- ring diseases of mucous membranes. Pure ocular cicatricial pemphigoid is a unique clinical and immunopathological entity distinct form of bullous pemphigoid and other subsets identified by antigenic specificity of autoantibodies. Arch Dermatol 1993; 129: 448-455
3. Borradori L, Bernard P. Pemphigoid group (bullous pem- phigoid, cicatricial pemphigoid. epidermolysis bullosa acquisita). In: Dermatology, Bolognia JL, Jorizzo JL, Rapini RP, editors. London: Elsevier Science, 2006: p. 431-445
4. Domloge-Hultsch N, Gammon WR, Briggaman RA, Gil SG, Carter WG, Yancey KB. Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease. J Clin Invest 1992; 90: 1628-1633
5. Chan LS, Majmudar AA, Tran HH, Meier F, Schaumburg-Lever G, Chen M, et al. Laminin-6 and Laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid. J Invest Dermatol 1997; 108: 848-853
6. Luke MC, Darling TN, Hsu R, Summers RM, Smith JA, Solomon BI, et al. Mucosal morbidity in patients with epidermolysis bullosa acquisita. Arch Dermatol 1999; 135: 954-959
7. Tyagi S, Bhol K, Natarajan K, Livir-Rallatos C, Foster CS, Ahmed AR. Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization. Proc Natl Acad Sci USA 1996; 93: 14714-14719
8. Assmann T, Becker J, Ruzicka T, Megahed M. Topical ta- crolimus for oral cicatricial pemphigoid. Clin Exp Dermatol 2004; 29: 674-676
9. Hall VC, Liesagang TJ, Kostick DA, Lookingbill DP. Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment. Arch Dermatol 2003; 139: 1083-1084
10. Gunther C, Wozel G, Meurer M, Pfeifer C. Topical tacro- limus treatment for cicatricial pemphigoid. J Am Acad Dermatol 2004; 50: 325-326